Our results also suggested that a compendium of CLL driver alterations such as SF3B1, alterations in cell cycle (CDKN2A/B), MYC, and NF-κB pathways could be acquired during the evolution of the disease. The gene discussed is CDKN2A; the disease is B-cell chronic lymphocytic leukemia.